Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

A Case Finding Study for Anderson-Fabry Disease Among Patients With Chronic Kidney Disease Not on Renal Replacement Therapy

NCT00728364•Klinikum Wels-Grieskirchen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Focus of Study: Prevalence of Fabry Disease in CKD Population

Locations

Austria

Locations (1)

Klinikum Wels-Grieskirchen

Wels, Upper Austria, Austria

Key Dates

Start Date

October 1, 2008

Primary Completion Date

August 1, 2011

Completion Date

December 1, 2011

Last Updated

April 12, 2012

Sponsors

Lead Sponsor

Klinikum Wels-Grieskirchen

Collaborators

Genzyme, a Sanofi Company

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions